GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (A0LI16)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (A0LI16) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A0LI16
Type
protein
Length
411 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xb4D2d9c96b0D792d0b77e7147D724cc1F801ae58
Molecule
Serine hydroxymethyltransferase
UniProt
A0LI16
Pockets
2 · best druggability 0.47

Structure

1 distinct chain · 50% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41150% helix, 14% strandA0LI16

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11790.470.7621empty
21700.470.7633empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.